Bone Mineralisation: Studies examining the effect of pulsatile GH release on osteoblast function and bone density in animal models
The decision to continue, reduce, or stop semaglutide should be made with your healthcare provider based on symptom severity, the benefit you are receiving from the medication, and alternative management options
In peptide medicine communities, reported protocols commonly range from 200-500 mcg once or twice daily, often used in short cycles lasting several weeks
Maintaining Long-Term Success The goal of switching is to stay on track with your long-term health goals
Over the last few years, GLP-1 receptor agonists like semaglutide and tirzepatide have become household names in metabolic health, weight loss, and diabetes care